By Reuters
NYT U.S.
The U.S. government will pay $1.95 billion to buy 100 million doses of Pfizer Inc and German biotech firm BioNTech SE's COVID-19 vaccine candidate if they are able to successfully develop one, the companies said on Wednesday.
Published date: July 22, 2020 at 02:18PM
Reuters
New York Times article
No comments:
Post a Comment